(Q35208510)

7 August 2017

1 reference

title

Molecular pathogenesis of thyroid cancer (English)

1 reference

7 August 2017

3

Martha A Zeiger

1 reference

7 August 2017

1

Dorry L Segev

1 reference

7 August 2017

Christopher Umbricht

2

1 reference

7 August 2017

publication date

1 August 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

12

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

69-90

1 reference

Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: basic aspects

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Molecular pathogenesis of thyroid nodules and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The relative roles of endemic goiter and socioeconomic development status in the prognosis of thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Molecular genetics of human thyroid neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Oncogenes and growth factors in thyroid carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Oncogenes and anti-oncogenes in human epithelial thyroid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Genetic alterations in human epithelial thyroid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Origin and progression of thyroid epithelial tumours: cellular and molecular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Molecular diagnostic tests in the diagnosis and management of thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Creation of human tumour cells with defined genetic elements

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Inverse association between cyclin D1 overexpression and retinoblastoma gene mutation in thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Gene rearrangements in radiation-induced thyroid carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Growth factors and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Factors controlling proliferation and differentiation of canine thyroid cells cultured in reduced serum conditions: effects of thyrotropin, cyclic AMP and growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosph

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Iodide symporter gene expression in human thyroid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Genetic alterations in thyroid hyperfunctioning adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Expression of thyrotrophin receptor gene in thyroid carcinoma is associated with a good prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Studies of the human TSH receptor gene in physiology and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Analysis of human TSH receptor gene and RNA transcripts in patients with thyroid disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The GTPase superfamily: conserved structure and molecular mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer-introduced restriction analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Activating point mutations of the gsp oncogene in human thyroid adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Two G protein oncogenes in human endocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Mutational activation of RAS and GSP oncogenes in differentiated thyroid cancer and their biological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Epidermal growth factor receptors and adenylate cyclase activity in human thyroid tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Control of protein synthesis by thyrotropin and epidermal growth factor in human thyrocytes: role of morphological changes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Differential protein phosphorylation in induction of thyroid cell proliferation by thyrotropin, epidermal growth factor, or phorbol ester

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Abnormalities of the EGF receptor system in human thyroid neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Immunohistochemical demonstration of epidermal growth factor and c-myc oncogene product in normal, benign and malignant thyroid tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Epidermal growth factor receptor and thyrotropin response in human thyroid tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Epidermal growth factor receptor signaling activates met in human anaplastic thyroid carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I-binding protein content in human thyroid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Evidence for autocrine production of IGF-1 in human thyroid adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Loss of dependence on IGF-1 for proliferation of human thyroid adenoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Thyroid angiogenesis: endotheliotropic chemoattractant activity from rat thyroid cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Mitogenic stimulation of normal and oncogene-transformed human thyroid epithelial cells by hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Mechanism of met oncogene activation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Expression of Met protein in thyroid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Negative/low expression of the Met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The MYC protein activates transcription of the alpha-prothymosin gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Oncogenic activity of the c-Myc protein requires dimerization with Max.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

New light on Myc and Myb. Part I. Myc.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Induction of the c-fos oncogene by thyrotropic hormone in rat thyroid cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Structure and expression of nuclear oncogenes in multi-stage thyroid tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Expression of the myc cellular proto-oncogene in human thyroid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

1 reference

7 January 2021

Predisposition to neoplastic transformation caused by gene replacement of H-ras1.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Histomorphological and immunohistochemical evidence that human nodular goiters grow by episodic replication of multiple clusters of thyroid follicular cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Multiple mechanisms of interference between transformation and differentiation in thyroid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

H-ras protooncogene mutations in human thyroid neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Ras oncogene mutations in benign and malignant thyroid neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Ras mutations are rare in solitary cold and toxic thyroid nodules

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Prevalence of Ras mutations in thyroid neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Point mutations of ras oncogenes are an early event in thyroid tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

RAF/RAS oncogenes and mismatch-repair status

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

BRAF Mutation in Papillary Thyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Ret and trk proto-oncogene activation in thyroid papillary carcinomas in French patients from the Champagne-Ardenne region

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Low rate of ret proto-oncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Continued expression of a tissue specific activated oncogene in the early steps of radiation-induced human thyroid carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Analysis of ret/PTC Gene Rearrangements Refines the Fine Needle Aspiration Diagnosis of Thyroid Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Hürthle cell tumors: using molecular techniques to define a novel classification system

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Molecular Basis of Hurthle Cell Papillary Thyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Expression of the trk proto-oncogene is restricted to the sensory cranial and spinal ganglia of neural crest origin in mouse development

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The cyclin-dependent protein kinases and the control of cell division.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Cyclin D1 overexpression in thyroid carcinomas: relation with clinico-pathological parameters, retinoblastoma gene product, and Ki67 labeling index

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Overexpression of Cyclin D1 and Underexpression of p27 Predict Lymph Node Metastases in Papillary Thyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Cyclin D1 expression is regulated by the retinoblastoma protein

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Loss of heterozygocity at the thyroid peroxidase gene locus in solitary cold thyroid nodules

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Thyroperoxidase (TPO) immunostaining of the solitary cold thyroid nodule

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The value of thyroid peroxidase immunohistochemistry for preoperative fine-needle aspiration diagnosis of the follicular variant of papillary thyroid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Evaluation of the monoclonal antibody antithyroperoxidase MoAb47 in the diagnostic decision of cold thyroid nodules by fine-needle aspiration

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Thyroid peroxidase immunodetection as a tool to assist diagnosis of thyroid nodules on fine-needle aspiration biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Thyroperoxidase immunodetection for the diagnosis of malignancy on fine-needle aspiration of thyroid nodules

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Immunohistochemical study of ceruloplasmin, lactoferrin and secretory component expression in neoplastic and non-neoplastic thyroid gland diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Immunohistochemical demonstration of ceruloplasmin in follicular adenomas and thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Iron-binding proteins in thyroid tumours. An immunocytochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Dipeptidyl aminopeptidase IV in the cytologic diagnosis of thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Staining for dipeptidyl aminopeptidase IV activity in nodular thyroid diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Dipeptidyl Aminopeptidase IV Staining of Cytologic Preparations to Distinguish Benign from Malignant Thyroid Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Diagnostic usefulness of dipeptidyl aminopeptidase IV monoclonal antibody in paraffin-embedded thyroid follicular tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The expression of the high mobility group I(Y) mRNA in thyroid cancers: useful tool of differential diagnosis of thyroid nodules

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

1 reference

7 January 2021

Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of nontoxic goiter

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Expression of cytokines in the thyroid: thyrocytes as potential cytokine producers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Immunocytochemically detectable TGF-beta associated with malignancy in thyroid epithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Expression of transforming growth factor-beta1 and transforming growth factor-beta Type-II receptor mRNA in papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Alterations of p53 and expression of WAF1/p21 in human thyroid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Underexpression of p27/Kip in thyroid papillary microcarcinomas with gross metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Cyclin-dependent kinase inhibitor p27(Kip1) expression in thyroid cells obtained by fine-needle aspiration biopsy: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Structure of the human retinoblastoma gene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

E2F: a link between the Rb tumor suppressor protein and viral oncoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Functional interactions of the retinoblastoma protein with mammalian D-type cyclins

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The E2F transcription factor is a cellular target for the RB protein

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The role of RB in cell cycle control

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Thyroid adenocarcinomas secondary to tissue-specific expression of simian virus-40 large T-antigen in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

UV Irradiation Stimulates Levels of p53 Cellular Tumor Antigen in Nontransformed Mouse Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

p53 function and dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The p53 proto-oncogene can act as a suppressor of transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Integrins and anoikis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Overexpression of TTF-1 and PAX-8 restores thyroglobulin gene promoter activity in ARO and WRO cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Thyroid dysgenesis caused by PAX8 mutation: the hypermutability with CpG dinucleotides at codon 31.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Transcriptional regulation of the human sodium/iodide symporter gene by Pax8 and TTF-1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

PAX 8 activates the enhancer of the human thyroperoxidase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Pax8 has a key role in thyroid cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Follicular cells of the thyroid gland require Pax8 gene function

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Thyroid-specific gene expression in the multi-step process of thyroid carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Cytoplasmic accumulation of alpha-catenin in thyroid neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

E-cadherin expression in follicular carcinoma of the thyroid

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Clinical significance of E-cadherin expression in thyroid neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

[Prognostic value of e-cadherin in papillary thyroid carcinoma]

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Expression of the cadherin-catenin complex in well-differentiated human thyroid neoplastic tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Preferential expression of the cell adhesion molecule CD44 in papillary thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

A matter of life and cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Aging and cancer: are telomeres and telomerase the connection?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Telomeres, telomerase and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Multiple pathways to cellular senescence: role of telomerase repressors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Association of p16(INK4a) and pRb inactivation with immortalization of human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Telomerase activity in the differential diagnosis of papillary carcinoma of the thyroid

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The Bcl-2 protein family: arbiters of cell survival

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

1 reference

7 January 2021

The CD95 system and the death of a lymphocyte

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The PTEN tumor suppressor protein inhibits tumor necrosis factor-induced nuclear factor kappa B activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Considerations when analyzing the methylation status of PTEN tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

MDM2--master regulator of the p53 tumor suppressor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Possible Relation of p53 and mdm-2 Oncoprotein Expression in Thyroid Carcinoma: A Molecular-Pathological and Immunohistochemical Study on Paraffin-Embedded Tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Nuclear accumulation of MDM2 protein in well-differentiated papillary thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The expression of the MDM2 gene, a p53 binding protein, in thyroid carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Overexpression of p53 protein and MDM2 in papillary carcinomas of the thyroid: Correlations with clinicopathologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

Modelling the molecular circuitry of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2803%2900037-9

7 January 2021

10.1016/S0960-7404(03)00037-9

Identifiers

DOI

1 reference

7 August 2017

1 reference